Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Gastrointestinal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00081536
What this trial is testing

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 105
Not applicableUnknownNCT03356236
What this trial is testing

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Who this might be right for
Hepatocarcinoma
Yue Han 828
Early research (Phase 1)Study completedNCT00019006
What this trial is testing

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

Who this might be right for
Recurrent Colon CancerExtensive Stage Small Cell Lung CancerStage III Pancreatic Cancer+11 more
National Cancer Institute (NCI)
Not applicableTemporarily pausedNCT03253575
What this trial is testing

CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2

Who this might be right for
Adult Solid Tumor
Mitra RxDx, Inc. 800
Testing effectiveness (Phase 2)Ended earlyNCT00064259
What this trial is testing

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT03913182
What this trial is testing

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaApatinibRecurrence+1 more
Shanghai Chest Hospital 39
Early research (Phase 1)Ended earlyNCT01249443
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Who this might be right for
HIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more
AIDS Malignancy Consortium 17
Testing effectiveness (Phase 2)Study completedNCT00084617
What this trial is testing

Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+6 more
National Cancer Institute (NCI) 39
Not applicableStudy completedNCT06776185
What this trial is testing

Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Chen Xiaoping 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)UnknownNCT03940976
What this trial is testing

Afatinib in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (ESCC-A01)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 40
Testing effectiveness (Phase 2)Study completedNCT00003055
What this trial is testing

Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT06581315
What this trial is testing

Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAdjuvant Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 204
Testing effectiveness (Phase 2)Looking for participantsNCT06454578
What this trial is testing

Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection

Who this might be right for
Carcinoma, Hepatocellular
Qilu Hospital of Shandong University 30
Large-scale testing (Phase 3)UnknownNCT04237740
What this trial is testing

Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
RenJi Hospital 40
Not applicableStudy completedNCT00397540
What this trial is testing

The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, HepatocellularChronic Hepatitis B
Seoul National University Hospital 145
Testing effectiveness (Phase 2)Study completedNCT03322267
What this trial is testing

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

Who this might be right for
Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 26
Very early researchNot Yet RecruitingNCT07709299
What this trial is testing

Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection

Who this might be right for
Hepatocellular Carcinoma (HCC)
Royan Institute 6
Testing effectiveness (Phase 2)Ended earlyNCT00745134
What this trial is testing

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+6 more
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Ended earlyNCT03945799
What this trial is testing

Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 28
Next Page